Related Experiment Video
Updated: Mar 18, 2026

Multi-photon Imaging of Tumor Cell Invasion in an Orthotopic Mouse Model of Oral Squamous Cell Carcinoma
Published on: July 25, 2011
HGF/Met Signaling in Head and Neck Cancer: Impact on the Tumor Microenvironment
Stefan Hartmann1, Neil E Bhola2, Jennifer R Grandis3
1Department of Otolaryngology, University of California San Francisco, San Francisco, California. Department of Oral and Maxillofacial Plastic Surgery, University Hospital Würzburg, Würzburg, Germany.
Abstract:
Studies to date have revealed several major molecular alterations that contribute to head and neck squamous cell carcinoma (HNSCC) initiation, progression, metastatic spread, and therapeutic failure. The EGFR is the only FDA-approved therapeutic target, yet responses to cetuximab have been limited. Activation and cross-talk of cellular receptors and consequent activation of different signaling pathways contribute to limited activity of blockade of a single pathway. The hepatocyte growth factor (HGF) receptor, Met, has been implicated in HNSCC tumorigenesis and EGFR inhibitor resistance. HGF, the sole ligand of Met, is overexpressed in the tumor microenvironment. The role of HGF/Met signaling in proliferation, metastasis, and angiogenesis has been investigated in HNSCC, leading to clinical trials with various Met inhibitors and HGF antibodies. However, the role of the HGF/Met signaling axis in mediating the tumor microenvironment has been relatively understudied in HNSCC. In this review, we discuss the functional roles of Met and HGF in HNSCC with a focus on the tumor microenvironment and the immune system. Clin Cancer Res; 22(16); 4005-13. ©2016 AACR.
Insights
Head and neck squamous cell carcinoma (HNSCC) involves molecular changes. This review focuses on the HGF/Met signaling axis, its role in the tumor microenvironment, and the immune system in HNSCC.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- Head and neck squamous cell carcinoma (HNSCC) is driven by multiple molecular alterations.
- Current therapies targeting EGFR show limited efficacy due to pathway cross-talk.
- The HGF/Met signaling axis is implicated in HNSCC tumorigenesis and resistance to EGFR inhibitors.
Purpose of the Study:
- To review the functional roles of Met and HGF in HNSCC.
- To emphasize the understudied role of HGF/Met signaling in the tumor microenvironment.
- To explore the impact of HGF/Met signaling on the immune system within HNSCC.
Main Methods:
- Literature review of studies on HGF/Met signaling in HNSCC.
- Analysis of HGF/Met's role in HNSCC initiation, progression, metastasis, and therapeutic failure.
- Focus on HGF/Met's influence on the tumor microenvironment and immune response.
Main Results:
- EGFR is the sole FDA-approved target, but cetuximab response is limited.
- HGF/Met signaling contributes to HNSCC proliferation, metastasis, and angiogenesis.
- HGF is overexpressed in the tumor microenvironment, suggesting its importance.
Conclusions:
- HGF/Met signaling plays a significant role in HNSCC.
- Further investigation into HGF/Met's role in the tumor microenvironment and immune modulation is warranted.
- Targeting HGF/Met may offer new therapeutic strategies for HNSCC.
More Related Videos
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
11:28Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics
Published on: May 11, 2016
Related Concept Videos
The Tumor Microenvironment
The Tumor Microenvironment
Mitogens and the Cell Cycle
Regulation of Angiogenesis and Blood Supply
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Hedgehog Signaling Pathway